Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.25 (
MEKK1
)
1,856
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Calcineurin is a serine/threonine protein phosphatase that plays a critical role in many physiologic processes, such as T-cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. We determined that active
MEKK3
was capable of activating calcineurin/nuclear factor of activated T-cells (NFAT) signaling in cardiac myocytes and reprogramming cardiac gene expression. In contrast, small interference RNA directed against
MEKK3
and a dominant negative form of
MEKK3
caused the reduction of NFAT activation in response to angiotensin II in cardiac myocytes. Genetic studies showed that
MEKK3
-deficient mouse embryo fibroblasts failed to activate calcineurin/NFAT in response to angiotensin II, a potent NFAT activator. Conversely, restoring
MEKK3
to the
MEKK3
-deficient cells restored angiotensin II-mediated calcineurin/NFAT activation. We determined that angiotensin II induced
MEKK3
phosphorylation. Thus,
MEKK3
functions downstream of the AT1 receptor and is essential for calcineurin/NFAT activation. Finally, we determined that
MEKK3
-mediated activation of calcineurin/NFAT signaling was associated with the phosphorylation of
modulatory calcineurin-interacting protein 1
at Ser(108) and Ser(112). Taken together, our studies reveal a previously unrecognized novel essential regulatory role of
MEKK3
signaling in calcineurin/NFAT activation.
...
PMID:The essential role of MEKK3 signaling in angiotensin II-induced calcineurin/nuclear factor of activated T-cells activation. 1612 26
Calcineurin is a serine/threonine protein phosphatase that plays a critical role in many physiologic processes such as T-cell activation, skeletal myocyte differentiation, and cardiac hypertrophy. We previously showed that active
MEKK3
is capable of stimulating calcineurin/nuclear factor of activated T-cells (NFAT) signaling in cardiac myocytes through phosphorylation of
modulatory calcineurin-interacting protein 1
(
MCIP1
). However, the protein kinases that function downstream of
MEKK3
to mediate
MCIP1
phosphorylation and the mechanism of
MCIP1
-mediated calcineurin regulation have not been defined. Here, we show that MEK5 and big MAP kinase 1 (BMK1) function downstream of
MEKK3
in a signaling cascade that induces calcineurin activity through phosphorylation of
MCIP1
. Genetic studies showed that BMK1-deficient mouse lung fibroblasts failed to mediate
MCIP1
phosphorylation and activate calcineurin/NFAT in response to angiotensin II, a potent NFAT activator. Conversely, restoring BMK1 to the deficient cells restored angiotensin II-mediated calcineurin/NFAT activation. Thus, using BMK1-deficient mouse lung fibroblast cells, we provided the genetic evidence that BMK1 is required for angiotensin II-mediated calcineurin/NFAT activation through MICP1 phosphorylation. Finally, we discovered that phosphorylated
MCIP1
dissociates from calcineurin and binds with 14-3-3, thereby relieving its inhibitory effect on calcineurin activity. In summary, our findings reveal a previously unrecognized essential regulatory role of mitogen-activated protein kinase signaling in calcineurin activation through the reversible phosphorylation of a calcineurin-interacting protein,
MCIP1
.
...
PMID:Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1. 1641 48